| PERIOD ENDING | 31-Mar-03 | 31-Dec-02 | 30-Sep-02 | 30-Jun-02 | | Total Revenue | 5,707 | 9,068 | 5,758 | 5,092 | | Cost of Revenue | 3,381 | 7,693 | 2,695 | 9,391 | | | Gross Profit | 2,326 | 1,375 | 3,063 | (4,299) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,551 | 4,031 | 6,248 | 1,682 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| (3,544) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,225) | (2,656) | (3,185) | (2,437) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 72 | 155 | 96 | 103 | | Earnings Before Interest And Taxes | (1,153) | (2,501) | (3,089) | (2,334) | | Interest Expense | 297 | 305 | 282 | 268 | | Income Before Tax | (1,450) | (2,806) | (3,371) | (2,602) | | Income Tax Expense | 68 | 15 | 44 | 14 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,518) | (2,821) | (3,415) | (2,616) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,518) | (2,821) | (3,415) | (2,616) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,518) | ($2,821) | ($3,415) | ($2,616) |
|
1.52% Nasdaq 0.00%
Income Statement
